Pharmaceutical composition for muscular anabolism

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 35/20 (2006.01) A23L 1/302 (2006.01) A23L 1/305 (2006.01)

Patent

CA 2398990

A pharmaceutical composition suitable for enhancing muscular anabolism contains, per daily dose, at least 5 mg of anabolic initiators comprising anabolic growth factors, at least 0.12 g of protein equivalents of anabolic substrates and at least 3 g of anabolic facilitators comprising at least 1 g of creatine or its functional equivalent. The anabolic initiators may be derived from a non-denatured animal protein, non-denaturated being defined as having a F0 of less than 3Ø

L'invention concerne une composition pharmaceutique permettant d'améliorer l'anabolisme musculaire, qui contient, par dose quotidienne, au moins 5 mg d'initiateurs anabolisants renfermant des facteurs de croissance anabolisants, au moins 0,12 g d'équivalents protéiniques de substrats anabolisants et au moins 3 g de facilitateurs anabolisants renfermant au moins 1 g de créatine ou de son équivalent fonctionnel. Les initiateurs anabolisants peut être dérivés d'une protéine animale non dénaturée, non dénaturée étant définie comme ayant une valeur F¿0? inférieure à 3.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical composition for muscular anabolism does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition for muscular anabolism, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for muscular anabolism will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1518031

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.